PUBLIC COMPANY
save$SGMTSagimet Biosciences Inc.
$SGMTSan Mateo, CA, USupdated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
- phase1A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
- phase3A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH
- phase3A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis
- phase2Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
- phase2Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
- phase1A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that